These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 14716362
1. [Role of hormone replacement therapy in the prevention and treatment of menopausal osteoporosis]. Landa MC. An Sist Sanit Navar; 2003; 26 Suppl 3():99-105. PubMed ID: 14716362 [Abstract] [Full Text] [Related]
2. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy. Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C. J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729 [Abstract] [Full Text] [Related]
9. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system? Rosano GM, Vitale C, Fini M. Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159 [Abstract] [Full Text] [Related]
10. [Evidence of hormone replacement therapy for osteoporosis]. Tarakida A, Higuchi T, Mizunuma H. Clin Calcium; 2008 Oct; 18(10):1434-41. PubMed ID: 18830040 [Abstract] [Full Text] [Related]
11. [Conventional hormonal replacement therapy in treatment of osteoporosis]. Meczekalski B, Czyzyk A. Pol Merkur Lekarski; 2009 Jul; 27(157):72-6. PubMed ID: 19650436 [Abstract] [Full Text] [Related]
12. Hormone therapy in the WHI era. Burger HG. Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):84-91. PubMed ID: 16638027 [Abstract] [Full Text] [Related]
13. A comparative review of the risks and benefits of hormone replacement therapy regimens. Warren MP. Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656 [Abstract] [Full Text] [Related]
14. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Skouby SO, Al-Azzawi F, Barlow D, Calaf-Alsina Erdogan Ertüngealp J, Gompel A, Graziottin A, Hudita D, Pines A, Rozenberg S, Samsioe G, Stevenson JC, European Menopause and Andropause Society. Maturitas; 2005 May 16; 51(1):8-14. PubMed ID: 15883103 [Abstract] [Full Text] [Related]
15. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Recent evidence of estrogen therapy for osteoporosis]. Higuchi T, Mizunuma H. Clin Calcium; 2008 Aug 16; 18(8):1141-6. PubMed ID: 18677052 [Abstract] [Full Text] [Related]
16. Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60. Studd J. Climacteric; 2009 Jun 16; 12(3):206-9. PubMed ID: 19437196 [Abstract] [Full Text] [Related]
17. [Hormone replacement Up-to-date. Effect of estrogen therapy (EP) and estrogen-progestogen therapy (EPT) on the bone metabolism]. Taniguchi R, Higuchi T, Mizunuma H. Clin Calcium; 2007 Sep 16; 17(9):1342-8. PubMed ID: 17767022 [Abstract] [Full Text] [Related]
18. Undertreatment of menopausal symptoms and novel options for comprehensive management. Lewis V. Curr Med Res Opin; 2009 Nov 16; 25(11):2689-98. PubMed ID: 19775194 [Abstract] [Full Text] [Related]
19. Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy. Richman S, Edusa V, Fadiel A, Naftolin F. Menopause; 2006 Nov 16; 13(1):148-55. PubMed ID: 16607111 [Abstract] [Full Text] [Related]
20. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Stefanick ML. Am J Med; 2005 Dec 19; 118 Suppl 12B():64-73. PubMed ID: 16414329 [Abstract] [Full Text] [Related] Page: [Next] [New Search]